See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Top Rated

Diabetes Pharmacy Article Archives

May 2014

Ousting Tobacco: After CVS Announcement, Push Intensifies to Ban Pharmacy Cigarettes Sales

When pharmacy giant CVS Caremark recently announced that it would cease selling tobacco products in its 7,600 stores as of October 1, it was talking about a significant piece of change: Estimates of CVS's current tobacco sales range from $1.5 billion to $2 billion, constituting about 1.6 to 3 percent of its earnings.

comments 0 comments - Posted May 29, 2014

April 2014

Robotics Allow Pharmacists to Spend More Time with Customers

There was a time when most people knew their corner pharmacist - like Mr. Gower in It's a Wonderful Life - and visits to the drug store included personal conversations to catch up on neighborhood and news, besides the dispensing of medications.

comments 1 comment - Posted Apr 14, 2014

May 2012

The State of the States: Adherence Report

Diabetes Health recently submitted some questions to CVS Caremark Corporation regarding its "The State of the States: Adherence Report." The report compiled data from more than 50 million patients to track their level of adherence to drug prescriptions for four chronic diseases: diabetes, depression, high blood pressure, and high cholesterol.

comments 2 comments - Posted May 4, 2012

November 2011

Diabetes Supply Costs Rule My Life!

There's nothing quite like wondering how you're going to pay for prescriptions.  I find it odd that we usually don't know what our out-of-pocket cost will be until we're standing in front of the pharmacy staff and praying that we have enough in our wallet to cover it.  I often feel like a reality show contestant waiting for the grand total.  My pharmacy-based reality show would probably be called "The Biggest Payer," or perhaps "The Amazing Guess," or, aptly, "Survivor."  If you've ever walked away from the pharmacy counter embarrassed, panicked, or depressed, you know the feeling I'm referring to.  It's a pain no prescription can cure.

comments 38 comments - Posted Nov 26, 2011

July 2011

Tradjenta, a Drug for Type 2s, Now on U.S. Market

Boehringer Ingelheim and Eli Lilly have begun sales of Tradjenta, a drug for type 2 diabetes, in U.S. pharmacies. The drug (generic name linagliptin) comes in tablet form and is intended to compete with Amylin Pharmaceuticals' Byetta, which is injected, and Merck's Januvia, which also competes with Byetta. Both are well-established in the U.S. market.

comments 2 comments - Posted Jul 27, 2011

NeuroMetrix and Nipro Team Up to Market Neuropathy Test

Nipro Diagnostics, Inc., and NeuroMetrix, Inc., have announced that they will seek opportunities to sell their soon-to-be-introduced NC-stat® DPNCheckTM neuropathy test in retail medical clinics nationwide. The test, conducted onsite, evaluates neuropathies, including diabetic peripheral neuropathy (DPN).

comments 1 comment - Posted Jul 16, 2011

June 2011

FDA Moves to Restrict Access to Three GSK Diabetes Drugs

The U.S. Food and Drug Administration has said that starting on November 18, 2011, it will restrict retail pharmacy sales of three diabetes drugs manufactured by GlaxoSmithKline: the stand-alone Avandia (rosiglitazone) and the combination drugs Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride).

comments 0 comments - Posted Jun 11, 2011

Telemed Service Integrates Physician-Pharmacy-Patient Interactions

The makers of "PhoneMyDoctor," a new telemedicine service, say it offers the ability integrate patient calls, doctor feedback, pharmacy ordering, and follow-up instructions into one documented record, using a medical practice's existing telephone equipment.

comments 0 comments - Posted Jun 7, 2011

May 2011

The Evolution of UltiMed’s 50-Count Pen Needle Box

There's more to that little box of pen needles than meets the eye, according to Holly Hartshorn of UltiMed. In early March, UltiMed launched a 50-count box of UltiCare pen needles into the marketplace. We spoke to Holly to find out exactly what kind of thought goes into such a product before it appears on pharmacy shelves.  

comments 3 comments - Posted May 17, 2011

April 2011

Jeff and Natalie Kolok: The Definition of Parenting

Jeff and Natalie Kolok live in northwestern Vermont with their three children: Naomi, 16, and Johanna and Nicholas, each ten years old. Both Johanna and Nicholas have type 1 diabetes, Johanna since age four and Nick since age six.  

comments 0 comments - Posted Apr 7, 2011

February 2011

A New Kind of Pharmacist

Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, Paul Lofholm, PharmD, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.

comments 0 comments - Posted Feb 21, 2011

A New Kind of Pharmacist

Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, pharmacist Paul Lofholm, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.

comments 0 comments - Posted Feb 20, 2011

Need Medicine and Have No Insurance for Your Diabetes?

Nearly one in six people in the United States has no health insurance. If you have diabetes, that's a very tough position to be in. There are, however, resources that can cut the costs that you have been paying out of pocket for medicines and supplies.

comments 0 comments - Posted Feb 14, 2011

November 2010

Drug Shortage Worries the Medical Community, Calls for Emergency Action

The newest threat to patient health may not be the flu or other epidemics. It could be a major shortage of prescription drugs. The shortage has reached the level of a "national public health crisis," according to a survey conducted by the Institute for Safe Medication Practices (ISMP) this summer. Survey respondents said shortages in the past year were "the worst ever, without a glimmer of hope for any improvement in the near future."

comments 0 comments - Posted Nov 27, 2010

October 2009

Grapefruit and Metformin May Have Ill Effects on the Body's pH Levels

A South African university pharmacologist has found that simultaneous consumption of metformin and grapefruit juice raises lactic acid to dangerous levels in rats (and conceivably in people) with type 2 diabetes. Too much acid in the blood can cause low pH levels that interfere with the body's metabolic functions. Conceivably, says Dr. Peter Owira, a pharmacologist at the University of KawZulu-Natal, such low levels could be fatal.

comments 6 comments - Posted Oct 26, 2009

June 2009

Doctors Urged to Stop Accepting Bri- —Oops, Make That Gifts—From Big Pharma

Drug companies spend billions of dollars on research, and it's obvious that they spend more billions on advertising. Well, according to the New York Times, they spend the most billions on giving nice things to doctors: pens, samples, banquets, trips, and educational opportunities among them. For doctors, in fact, there is a free lunch: Pharma companies spend as much as a billion a year just on lunches for doctors. And over 90 percent of doctors have accepted at least some of this largesse from the industry.

comments 5 comments - Posted Jun 12, 2009

March 2009

Insulin For Type 2 Diabetes: Who, When, And Why?

Physicians who treat people with type 2 diabetes face difficult choices when selecting the best medical therapy for each patient. The decision process is further complicated by the fact that because type 2 diabetes is a progressive disease, therapeutic agents that were initially successful may fail five or ten years later.

comments 159 comments - Posted Mar 20, 2009

December 2008

Women Have Double the Fracture Risk with Avandia and Actos

Avandia (rosiglitazone) and Actos (pioglitazone), two medications used to lower blood sugar in type 2 patients, double the risk of fractures in women, but not in men, says a new study.

comments 0 comments - Posted Dec 22, 2008

FDA Asks Diabetes Drug Makers To Study Their Medicines’ Potential Heart Risks
FDA Asks Diabetes Drug Makers To Study Their Medicines’ Potential Heart Risks

The U.S. Food and Drug Administration has recommended that companies manufacturing diabetes treatment drugs provide evidence that their products will not increase cardiovascular risks.

comments 0 comments - Posted Dec 22, 2008

August 2008

Love Thy Pharmacist: Prescription Drugs in Mexico Might Not Be What They Seem

If your summer travels take you south of the border into Mexico, pharmacists say you should avoid the temptation of saving a few dollars by purchasing your medications at farmacias, which sell versions of American prescription drugs made in Mexico.

comments 5 comments - Posted Aug 5, 2008

June 2008

Diabetes Drugs Are Now the Top Driver In Drug Spending Growth, Says Report
Diabetes Drugs Are Now the Top Driver In Drug Spending Growth, Says Report

Diabetes treatments are now the leading driver of prescription drug spending growth, displacing lipid-lowering drugs, which tumbled in price after a reign of 10 years in the top position. Generic drugs are cutting the cost of treating high cholesterol.

comments 2 comments - Posted Jun 12, 2008

March 2008

Legal and Illegal Drugs: What Every Person With Diabetes Should Know Before They Party

Perhaps more than anyone, people with diabetes know that the motto “Just say no” often doesn’t work.

comments 31 comments - Posted Mar 13, 2008

December 2007

Bayer Recalls Test Strips After False Readings

Bayer Diabetes Care has recalled 230,000 bottles of Contour TS test strips after finding that the strips resulted in blood glucose readings 5 to 17 percent higher than actual levels.

comments 0 comments - Posted Dec 29, 2007

November 2007

An Insulin Prescription for Disaster

In July, I flew from New York City to Phoenix to meet my new book agent. (Trust me, I would not have deliberately sought out 100-degree weather without good reason.) Always thinking ahead, I decided to bring along a fancy new bag specially insulated to keep my insulin cool. Alas, either the bag failed me, or I failed the bag.

comments 3 comments - Posted Nov 25, 2007

Lazarus Takes on Test Strip Gouging

Los Angeles Times columnist and newly diagnosed type 1 David Lazarus is becoming quite an advocate for people with diabetes.

comments 4 comments - Posted Nov 10, 2007

October 2007

Black Box Warning For Actos and Avandia

The FDA has spoken: the heart risk warnings on labels of Avandia (rosiglitazone) and Actos (pioglitazone) will now be surrounded by an emphatic black outline known as a black box. Black boxes will also be added to the warnings on Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepiride).

comments 3 comments - Posted Oct 31, 2007

Actos and Avandia Cost Plenty

According to Greek researchers, Actos and Avandia were behind a tripling of the cost of medicines used to treat Athenians with type 2 diabetes over the past eight years.

comments 0 comments - Posted Oct 10, 2007

Actos and Avandia: New Heart Risk Studies

The September 2007 Journal of the American Medical Association (JAMA) has published two new studies, one a meta-analysis of Avandia (rosiglitazone) and the other a meta-analysis of Actos (pioglitazone).

comments 0 comments - Posted Oct 5, 2007

August 2007

Save A Few Billion: Buy Generic Drugs

Americans spend 275 billion dollars on prescription medicines every single year, sixty percent of it on generics. But in the next five years, the twenty-year patents are going to expire on enough brand-name medicines to account for about 60 billion dollars of that total. And the generics that spring up to replace those drugs will be thirty to eighty percent cheaper.

comments 3 comments - Posted Aug 26, 2007

Adverse Interactions of Drugs with Natural Health Products Are Under-Reported

According to a literature review and survey of 132 Canadian pharmacists, 47 percent of pharmacists have encountered an adverse interaction between a natural health product and a drug.

comments 0 comments - Posted Aug 13, 2007

Wal-Mart Settles Wrongful Death Suit Due to Insulin Overdose
Wal-Mart Settles Wrongful Death Suit Due to Insulin Overdose

On December 13, 2005, Keith Scofield visited a Wal-Mart pharmacy in Frederick, Maryland, and ordered over-the-counter Humulin R (u-100). Instead, he was allegedly given Humulin R (u-500), a prescription drug that contains five times the insulin of the requested medication.

comments 3 comments - Posted Aug 7, 2007

The Latest About Avandia and Actos

On July 30, 2007, a Food and Drug Administration (FDA) panel voted 22 to 1 to keep Avandia on the market, right after agreeing by a vote of 20 to 3 that Avandia does increase heart risks. Now the FDA will decide what kind of warning should appear on the Actos and Avandia labels. It has already called for a black box warning, the sternest possible, on Avandia.

comments 0 comments - Posted Aug 1, 2007

July 2007

Amid Accusatory Debate, FDA Puts Black Box Warning on Avandia and Actos

In a congressional hearing on June 13, 2007, the Food and Drug Administration (FDA) revealed that it has called for a black box warning, the sternest possible, on both Actos and Avandia.

comments 0 comments - Posted Jul 12, 2007

May 2007

Updated: Analysis Associates Avandia With Greater Risk of Heart Attack

Analysis of several recent studies indicates that Avandia (rosiglitazone), a type 2 diabetes medication that's been taken by more than six million people worldwide, is associated with a 43 percent increased risk of heart attack and with a borderline-significant increased risk of heart attack-related death.

comments 0 comments - Posted May 31, 2007

Misreading Avandia

The recent ruckus over the drug rosiglitazone (Avandia) has been portrayed as another case of Big Pharma foisting a dangerous drug on the public while the overworked FDA can't keep up.

comments 0 comments - Posted May 31, 2007

Get Yourself and Your Supplies Overseas Safely
Get Yourself and Your Supplies Overseas Safely

Because of recent changes in airline regulations concerning the transportation of medication, diabetics have more to lose than just their lotion or soda. Now more than ever, it is important to know how to notify security and flight personnel of your medical needs, what documentation to bring, and where to find supplies if yours are damaged.

comments 0 comments - Posted May 21, 2007

April 2007

Swallowing Insulin Might Delay Type 1

For people who develop type 1 diabetes, the autoimmune attack on beta cells actually starts up to ten years before diabetes is diagnosed, when autoantibodies first appear in the blood and begin attacking the beta cells.

comments 0 comments - Posted Apr 17, 2007

Hey Doc, Let’s Fly to Maui To Talk About Drugs
Hey Doc, Let’s Fly to Maui To Talk About Drugs

In 1997, Minnesota became the first of a handful of states to pass a law requiring drug makers to disclose payments made to doctors. Its records reveal that over twenty percent of the state’s physicians have received such payments, generally for giving speeches about drugs to other doctors.

comments 0 comments - Posted Apr 10, 2007

March 2007

Dr. White Answers Your Medication Questions

Q: Are there any long-term side effects of the popular drugs to treat type 2 diabetes?

comments 2 comments - Posted Mar 24, 2007

Good Neighbor Pharmacy To Be Official Medical Supply Sponsor Of Eight Ironman Events: Good Neighbor Pharmacy’s Diabetes Shoppe also sponsors “Iron Andy” Holder

Valley Forge, Pa. - Good Neighbor Pharmacy®, a 25 year old network of independently owned pharmacies with over 2,700 locations nationwide, is proud to be the “Official Medical Supply” sponsor of the 2007 Ironman 70.3 California and seven other Ironman events.

comments 0 comments - Posted Mar 20, 2007

July 2006

Drug Called Safe for the Management of Pain From Diabetic Nerve Damage

A long-term study published in a recent issue of the Journal of Palliative Medicine found that Eli Lilly’s non-narcotic prescription drug Cymbalta (duloxetine HCl) is as safe and well-tolerated as current routine care that uses one or more medications for the management of pain caused by diabetic nerve damage. Study findings also show that Cymbalta did not adversely affect the progression of diabetes or many of the complications associated with the illness, such as damage to the nerves, kidneys and eyes.

comments 0 comments - Posted Jul 1, 2006

May 2006

Apidra Now on Pharmacy Shelves
Apidra Now on Pharmacy Shelves

On February 28, 2006, sanofi-aventis announced that its fast-acting Apidra (insulin glulisine [rDNA origin] injection) is now available by prescription in the United States. Apidra was granted FDA approval in April 2004.

comments 1 comment - Posted May 1, 2006

April 2006

Actos Alone or Combined With Oral Meds Improves Your Patient’s BGs and Lipids

New Zealand researchers say that in clinical trials of people with type 2 diabetes, Actos as stand-alone therapy or in combination with metformin, repaglinide, insulin or a sulphonylurea induced “both long- and short-term improvements in [blood glucose] control and serum lipid profiles.”

comments 0 comments - Posted Apr 1, 2006

Is Mail Order the Right Option for You?
Is Mail Order the Right Option for You?

When it’s time to restock your diabetes medications and supplies, have you ever wished that you didn’t have to make that trip to the pharmacy? Wouldn’t you like to avoid the lines, the traffic or parking hassles, and having to find your prescription for the refill?

comments 2 comments - Posted Apr 1, 2006

January 2006

Is Pargluva On the Ropes?

It was the belle of the ball at last summer’s ADA Scientific Sessions in San Diego. Now it appears that muraglitazar (Pargluva) is clinging to life after a scathing report recently published by the Journal of the American Medical Association.

comments 0 comments - Posted Jan 1, 2006

Ordering Infusion Supplies Online
Ordering Infusion Supplies Online

Many pump manufacturers have online stores where you can order and pay for your infusion supplies. In addition to manufacturer Web sites, services are offered by Advantage Rx, CCS Medical, Fifty 50 Pharmacy, Focus Pharmacy, Logimedix and National Diabetic Pharmacy. In Canada, supplies can be obtained from AutoControl Medical.

comments 0 comments - Posted Jan 1, 2006

October 2005


Actos (pioglitazone HCl) is an oral agent for type 2 diabetes belonging to the thiazolidinedione (TZD) class of drugs. TZDs help lower insulin resistance, a core dysfunction in people with type 2. They act by helping the body use its available amounts of insulin more effectively. Actos is known as an “insulin sensitizer” because it directly targets insulin resistance, a condition in which the body cannot use the insulin it produces efficiently.

comments 0 comments - Posted Oct 1, 2005

September 2005

Actos May Improve Heart Safety in Type 2s

Actos, an insulin sensitizer in the glitazone class of type 2 oral diabetes medications, was found to reduce carotid artery intima-media thickness (IMT) as well as insulin resistance in a German study.

comments 0 comments - Posted Sep 1, 2005

July 2005

Byetta Now Available for Type 2s

“People who are no longer successful on oral agents can now add Byetta [exenatide] instead of insulin,” says Anne Peters, MD, director of the USC Clinical Diabetes Programs.

comments 1 comment - Posted Jul 1, 2005

April 2005

Prescriptions By Mail
Prescriptions By Mail

Convenience! No insurance or Medicare claims! No paperwork! These are just some of the reasons that many people with diabetes order their medications and supplies through the mail instead of picking them up at the pharmacy.

comments 0 comments - Posted Apr 1, 2005

November 2004

Diabetes Educator of the Month: Susan B. Sloane, BS, Rph, CDE
Diabetes Educator of the Month: Susan B. Sloane, BS, Rph, CDE

Susan B. Sloane, BS, Rph,CDE, has been a registered pharmacist for more than 20 years and a certified diabetes educator for 15 years.

comments 2 comments - Posted Nov 1, 2004

October 2004

A Pharmacist’s Guide to Herbs and Supplements for Diabetes

Always inform your healthcare professional about any and all herbals or supplements that you may be taking.

comments 0 comments - Posted Oct 1, 2004

April 2004

Mail Order: A Convenient Option for People With Diabetes

Several years ago, the dot-com phenomenon was making millionaires out of anybody with an idea for selling a product or service online.

comments 0 comments - Posted Apr 1, 2004

April 2003

The Importance of Doing Your Homework When Investing

Walk into any pharmacy and pay close attention to the diabetes display. More than likely, you will find the display fairly close to the pharmacist's counter.

comments 0 comments - Posted Apr 1, 2003

February 2001

Mail-Order Insulins Can Go Bad

Many people with diabetes suspect that the insulin they get by mail sometimes has lost its effectiveness. Now, a study has proven their suspicions are probably true, causing the medical community to question mail-order pharmacies and bring people back to their community pharmacies, where face-to-face treatment delivers to them the best care possible.

comments 0 comments - Posted Feb 1, 2001

December 1999

Pharmacy Profession Ranks Isolation of Insulin as a Major 20th Century Event

In the October issue of Drug Topic magazine, the isolation of insulin was ranked as one of the top five events in the pharmacy profession for the 20th century.

comments 0 comments - Posted Dec 1, 1999

Why are Some Drugs So Expensive?—Endocrinologist Tells Consumer to Shop Around

One year ago, I was standing in line at a local pharmacy to purchase a prescription drug for my wife. The woman in front of me had given the pharmacist a prescription for a mild agent to help her son sleep. This drug is neither essential nor even clearly effective. As the pharmacist gave the woman the bottle of 30 pills, he asked her for $204.

comments 0 comments - Posted Dec 1, 1999

September 1999

Avandia and ACTOS Hit The Ground Running—Rezulin Competitors Show No Liver Toxicity in Clinical Trials

Two new drugs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. In clinical trials, Avandia (rosiglitazone maleate) and ACTOS (pioglitazone hydrochloride) lowered blood sugars an average of 76 mg/dl and 95 mg/dl respectively, when compared to a placebo.

comments 0 comments - Posted Sep 1, 1999

December 1998

Herb Buyers Beware

Dori Linnell of Eureka, Montana, would do anything for Tel, her 5-year-old son with diabetes. With diligence, knowledge and love, she has kept his HbA1cs in the nearly perfect range of 6.8 to 7.0 %. Linnell is obviously doing what works but always looking for something that may work better. She read about BetaFast, a product that is said to help people with diabetes control their blood sugars. BetaFast is made from the leaf extract of the herb Gymnema sylvestre, a climbing plant found in India. Always a believer in herbs, she wanted to try it with Tel.

comments 0 comments - Posted Dec 1, 1998

August 1998

Pharmacists Reduce Diabetes Treatment Cost

Asheville, North Carolina recently saved $25,000 in treating diabetes-related conditions under its self-funded health insurance program. The city owes its savings to a novel pilot project conceived by the North Carolina Center for Pharmaceutical Care in cooperation with Mission St. Joseph's Hospital System and local pharmacies.

comments 0 comments - Posted Aug 1, 1998

September 1997

Skin Care Products for Diabetics Now Available in Many Pharmacies

After years of searching for diabetic skin care treatments, Anastasia Marie Chehak developed a line of products called Diabetic Pure Skin Therapy¨. Chehak wanted to create a skin care system that would provide immediate relief as well as long-term therapeutic use. Chehak is a diabetes educator, registered dietitian, clinical nutritionist and a diabetic herself. In treating patients, she found that the typical over-the-counter skin creams didn't do much to improve the condition of her patients' skin.

comments 0 comments - Posted Sep 1, 1997

August 1994

Are You Utilizing The Services Of Your Pharmacy?

Your pharmacist and his staff screen a new prescription for errors, then enter the data into the computer. If a problem is noted the pharmacist will contact your physician. The prescription is dispensed to you and a face-to-face counseling session informs you how to take the medicine correctly, what possible side effects or adverse effects to be aware of, and what to do about a missed dose. Some computer programs also print out an information sheet about your prescription.

comments 0 comments - Posted Aug 1, 1994

March 1994

Leading Diabetes Pharmacist Talks About Daily Vitamin Supplements

Introduction: It was a long, difficult, and confusing road that lead me to the conclusion that as a person with diabetes (type I for 45 years), I should take vitamin, mineral, and trace element (micronutrient) supplements daily. My educational background, like that of most other health care providers, did not include much clinical information about the need for micronutrients. Most of the information presented concerned biochemical effects (the effects of vitamins on the chemical reactions of cells) or deficiency states due to an unbalanced diet. I can remember my professor summarizing vitamin use by saying "the vast majority of people in the United States don't need to take daily vitamin supplements, as long as they consume well-balanced and nutritious meals each day." He also emphasized the lack of long-term clinical studies about micronutrient supplementation. My professor categorized the people who probably needed supplements as: children during growth stages, pregnant and lactating women, elderly patients, individuals with specific vitamin deficiencies, patients with chronic conditions, alcoholics, individuals under stress, and those who did not follow a well-balanced diet. I added up all the people in these categories and realized that a relatively high percentage of the total US population might need daily supplements.

comments 1 comment - Posted Mar 1, 1994

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.